These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 5960083)

  • 1. [Formation of N-glycosides of sulfonamides and their decomposition in the suppository masses containing acid substances].
    Sykulska Z
    Acta Pol Pharm; 1966; 23(6):523-30. PubMed ID: 5960083
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of drug decomposition. LXXII. Stability of the preparation Clofenazon in the suppository base Vitepsol H-15].
    Pawełczyk E; Wachowiak R; Babelek T
    Acta Pol Pharm; 1982; 39(5-6):381-6. PubMed ID: 6133411
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on stability of drugs in lyophilized suppository bases. 1. Separation and detection of products of decomposition of cyclovegantine, ethionamide and euphylline by means of thin-layer chromatography].
    Cieszyński T
    Acta Pol Pharm; 1971; 28(1):59-69. PubMed ID: 5577813
    [No Abstract]   [Full Text] [Related]  

  • 4. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
    Regdon G; Deák D; Regdon G; Muskó Z; Erös I
    Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the stability of drugs in lyophilic suppository media. II. Evaluation of decay of cyclovegantine, ethionamide and euphylline in suppositories].
    Cieszyński T
    Acta Pol Pharm; 1971; 28(4):375-84. PubMed ID: 5145789
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decomposition of aminophylline in suppository formulations.
    Brower JF; Juenge EC; Page DP; Dow ML
    J Pharm Sci; 1980 Aug; 69(8):942-5. PubMed ID: 7400941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stability of drugs in lyophilic suppository bases. V. Identification of products of ethionamide decay isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(5):651-6. PubMed ID: 4447018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physical stability of suppository bases at different temperatures].
    Leszczyńska-Bakal H
    Acta Pol Pharm; 1971; 28(5):531-5. PubMed ID: 5145101
    [No Abstract]   [Full Text] [Related]  

  • 10. Study on stability of drugs in lyophilic suppository bases. 3. Isolation of cyclovegantine, ethionamide and euphyllin degradation products from suppositories.
    Cieszyński T
    Acta Pol Pharm; 1972; 29(1):75-83. PubMed ID: 5055291
    [No Abstract]   [Full Text] [Related]  

  • 11. A gradient HPLC method for the quality control of chlorogenic acid, linarin and luteolin in Flos Chrysanthemi Indici suppository.
    Zhang Q; Li J; Wang C; Sun W; Zhang Z; Cheng W
    J Pharm Biomed Anal; 2007 Jan; 43(2):753-7. PubMed ID: 16930915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug stability in lyophilic suppository media].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(2):257-8. PubMed ID: 4840677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kinetics of drug decomposition. XLI. Specific acid hydrolysis of sulfathiazole].
    Pawełczyk E; Zajac M
    Acta Pol Pharm; 1976; 33(4):479-84. PubMed ID: 970171
    [No Abstract]   [Full Text] [Related]  

  • 14. [The influence of thermal constraints on the liberation of the active principal from the suppository form: the case of acetylsalicylic acid].
    Lasserre Y; Peneva B; Jacob M; Puech A
    J Pharm Belg; 1986; 41(1):12-6. PubMed ID: 3701563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on the polymorphic transition of semisynthetic triglycerides of fatty acid suppository bases].
    Xie XH; Gu XC; Liu FY
    Yao Xue Xue Bao; 1988 May; 23(5):388-93. PubMed ID: 3213521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acetaminophen-containing suppositories in vitro and in vivo].
    Regdon G; Szikszay M; Gebri G; Regdon G
    Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a suppository formulation containing Lactobacillus and its application in vaginal diseases.
    Kale VV; Trivedi RV; Wate SP; Bhusari KP
    Ann N Y Acad Sci; 2005 Nov; 1056():359-65. PubMed ID: 16387701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Formulation and in vitro examination of furosemide-containing suppositories and preliminary experiences of their clinical use].
    Regdon G; Fazekas T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1997 Jan; 67(1):19-23. PubMed ID: 9163255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of aminophylline suppositories prepared in a hospital pharmacy.
    Fujii T; Kubota A; Togawa K; Mizushima N
    Tokai J Exp Clin Med; 1982 May; 7(3):371-83. PubMed ID: 7123575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal suppository insertion: the reliability of the evidence as a basis for nursing practice.
    Bradshaw A; Price L
    J Clin Nurs; 2007 Jan; 16(1):98-103. PubMed ID: 17181671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.